Limitations of systemic therapies for psoriasis
Psoriasis is a common inflammatory and proliferative dermatosis, with a prevalence of 1–3% in most ethnic groups. It is a chronic disease of variable severity and can cause considerable physical and psychosocial morbidity. Its impact on health-related quality of life is comparable to that of other major medical illnesses.
Dermatology in practice 2013; 19(1): 10–15
To continue reading this article, please sign in or register.